Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoemulsion Improves the Neuroprotective Effects of Curcumin in an Experimental Model of Parkinson’s Disease
Osmar Vieira Ramires Júnior, Barbara da Silva Alves, Paula Alice Bezerra Barros, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 3, pp. 787-799
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation
Anushruti Ashok, Syed Suhail Andrabi, Saffar Mansoor, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 122
Neuroprotective Activities of Curcumin in Parkinson’s Disease: A Review of the Literature
Eslam El Nebrisi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11248-11248
Open Access | Times Cited: 114
Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport
Shivani Gandhi, Divyesh H. Shastri, Jigar Shah, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 481-481
Open Access | Times Cited: 18
Neuro-nanotechnology: diagnostic and therapeutic nano-based strategies in applied neuroscience
Leili Shabani, Milad Abbasi, Zeynab Azarnew, et al.
BioMedical Engineering OnLine (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 37
Curcumin, inflammation, and neurological disorders: How are they linked?
Prachi Garodia, Mangala Hegde, Ajaikumar B. Kunnumakkara, et al.
Integrative Medicine Research (2023) Vol. 12, Iss. 3, pp. 100968-100968
Open Access | Times Cited: 33
Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases
Miriam Mistretta, Andrea Farini, Yvan Torrente, et al.
Brain (2023) Vol. 146, Iss. 6, pp. 2227-2240
Open Access | Times Cited: 25
Nose-to-Brain Targeting via Nanoemulsion: Significance and Evidence
Shashi Kiran Misra, Kamla Pathak
Colloids and Interfaces (2023) Vol. 7, Iss. 1, pp. 23-23
Open Access | Times Cited: 22
New Drug Delivery Systems Developed for Brain Targeting
Shruti Rawal, Bhoomika M. Patel, Mayur M. Patel
Drugs (2022) Vol. 82, Iss. 7, pp. 749-792
Closed Access | Times Cited: 28
Recent Trends and Practices Toward Assessment and Rehabilitation of Neurodegenerative Disorders: Insights From Human Gait
Ratan Das, Sudip Paul, Gajendra Kumar Mourya, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 27
Natural product-based pharmacological studies for neurological disorders
Vivek Puri, Neha Kanojia, Ameya Sharma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 23
Omega‐3 polyunsaturated fatty acids and Parkinson's disease: A systematic review of animal studies
Barbara da Silva Alves, Lúcia Emanueli Schimith, André Brito da Cunha, et al.
Journal of Neurochemistry (2024) Vol. 168, Iss. 8, pp. 1655-1683
Open Access | Times Cited: 4
Nanotechnology in Parkinson’s Disease: overcoming drug delivery challenges and enhancing therapeutic outcomes
Irfan Ali, Mohammad Adil, Mohammad Imran, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Mitochondria targeted nanoparticles for the treatment of mitochondrial dysfunction-associated brain disorders
Amy Claire Buck, Gerald J. Maarman, Admire Dube, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Application of curcuminoids in inflammatory, neurodegenerative and aging conditions - Pharmacological potential and bioengineering approaches to improve efficiency
Ricardo Lagoa, Rajan Logesh, Cristiana Violante, et al.
Biotechnology Advances (2025), pp. 108568-108568
Open Access
Potential therapeutic effects of curcumin, with or without L-DOPA, on motor and cognitive functions and hippocampal changes in rotenone-treated rats
Muaz Belviranlı, Nilsel Okudan, Tuğba Sezer
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Open Access
Neuroprotective effect of Withania somnifera leaves extract nanoemulsion against penconazole-induced neurotoxicity in albino rats via modulating TGF-β1/Smad2 signaling pathway
Mohamed Abomosallam, Basma M. Hendam, Amr A. Abdallah, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1903-1928
Open Access | Times Cited: 4
Relationship of Curcumin with Aging and Alzheimer and Parkinson Disease, the Most Prevalent Age-Related Neurodegenerative Diseases: A Narrative Review
Büşra Yurt Türer, Nevin Şanlıer
Nutrition Reviews (2024)
Closed Access | Times Cited: 4
Water balancing actions of sodium and potassium chlorides for curcumin antioxidant activities in oil-water nanoformulations
Parth Malik, Sunita Singh, Man Singh
Journal of Molecular Liquids (2024) Vol. 398, pp. 124266-124266
Closed Access | Times Cited: 3
Bambusa vulgaris attenuates Haloperidol-induced motor deficit and non-Motor co-morbidity in rats through up-regulation of Dopamine transmission and mitigation of pro-inflammatory cytokines activities
Abdullahi A. Murtala, Oyinloye E. Oladapo, Farouk Adedeji Oladoja, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100375-100375
Open Access | Times Cited: 3
Paradigms and Success Stories of Natural Products in Drug Discovery Against Neurodegenerative Disorders (NDDs)
Sukhwinder Singh, Shivani Chib, Md Jawaid Akhtar, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 6, pp. 992-1015
Open Access | Times Cited: 8
Exploring Nanocarriers for Boosting Entacapone Bioavailability: A Journey through System Characterization and Assessment of Toxicity and Pharmacological and 2D Permeability Paybacks
Cláudia Sofia Machado, Miguel Pinto, Brandon Aguiar, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 43, pp. 58299-58312
Closed Access | Times Cited: 2
Exploring the Neuroprotective Mechanism of Curcumin Inhibition of Intestinal Inflammation against Parkinson’s Disease Based on the Gut-Brain Axis
Lifan Zhong, Benchi Cai, Qitong Wang, et al.
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 39-39
Open Access | Times Cited: 12
Analysis of bioactive compounds in cinnamon leaves and preparation of nanoemulsion and byproducts for improving Parkinson’s disease in rats
Yi Chun Wang, Vinchi Wang, Bing‐Huei Chen
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 6
Nanophytomedicines as Therapeutic Agents for Parkinson’s Disease
Jessica Burns, Amy Claire Buck, Sarah D’ Souza, et al.
ACS Omega (2023) Vol. 8, Iss. 45, pp. 42045-42061
Open Access | Times Cited: 6
Preparation and Evaluation of Curcumin Derivatives Nanoemulsion Based on Turmeric Extract and Its Antidepressant Effect
Lin Sheng, Yumeng Wei, Chao Pi, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 7965-7983
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top